Over 300 Advanced CT Scanners Set to Transform Indonesia's Healthcare System Through 2028

GE HealthCare has revealed an ambitious healthcare modernization initiative involving the Indonesian Ministry of Health, marking a significant expansion of diagnostic capabilities across the nation. The multi-year partnership will deploy more than 300 state-of-the-art computed tomography scanners to public hospitals spanning all 38 Indonesian provinces, with full rollout targeted by 2028.

Strategic Focus on Disease Detection and Prevention

This initiative represents a critical shift in Indonesia’s approach to managing non-communicable diseases. The deployment prioritizes early detection and intervention for conditions including cancer, stroke, and cardiovascular disease—conditions that have historically posed diagnostic challenges in remote regions. By distributing advanced imaging technology across both urban centers and less accessible areas, the program addresses a persistent gap in diagnostic infrastructure.

The SIHREN Program Framework

Operating under the Strengthening Indonesia’s Health Referral Network (SIHREN) program, this initiative was competitively selected and operates under World Bank procurement standards. Beyond imaging equipment, the program encompasses broader healthcare modernization objectives, including enhanced maternal health services and improved pandemic preparedness capabilities.

Broader Healthcare System Improvements

The infrastructure investment extends beyond CT scanner installation. The partnership supports Indonesia’s national referral system modernization, enabling better coordination between facilities and improved patient outcomes. For a nation serving over 280 million people, this expansion dramatically increases access to diagnostic imaging that was previously limited to major urban centers.

The deployment aligns with Indonesia’s strategic healthcare agenda, addressing both immediate diagnostic needs and long-term health system resilience. Early disease detection capabilities are expected to reduce treatment complexity and associated healthcare costs while improving survival rates across the population.